MAPT and Alzheimer disease: However, studies involving experimental investigations on PAHs and pathological mechanisms (mitochondrial dysfunction, neuroinflammation, beta-amyloid aggregation, tau phosphorylation, formation of α-synuclein) associated with Parkinson’s disease and Alzheimer’s disease are still very few.